Radiolabeled somatostatin analogs in prostate cancer

Nuclear Medicine and Biology

Volumn 24, Issue 1, 1997, Pages 105-113

  Thakur, Mathew L ^a,d   Kolan, H ^a   Li, J ^a   Wiaderkiewicz, R ^b   Pallela, V R ^a   Duggaraju, R ^a   Schally, A V ^c  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

99mTc labeled octreotide; 99mTc labeled RC 160; imaging prostate cancer; radiolabeled somatostatin analogs; receptor specific peptides in prostate cancer

Indexed keywords

OCTREOTIDE TC 99M; OXYTOCIN TC 99M; PENTETREOTIDE IN 111; PENTREOTIDE IN 111; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG; VAPREOTIDE; VAPREOTIDE TC 99M;

ANIMAL EXPERIMENT; ARTICLE; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; PROSTATE CANCER; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; HUMANS; MALE; MICE; MICE, NUDE; OCTREOTIDE; OXYTOCIN; PROSTATIC NEOPLASMS; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; TECHNETIUM COMPOUNDS; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0030975591     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(96)00180-1     Document Type: Article

References (36)

1. American Cancer Society (1992) Cancer Facts and Figures. N.Y.
2. Babaian R. J., Murray J. L., Lamki L. M., Haynie T. P., Hersh, E. M., Rosenblum M. G., Glenn H. J., Unger M. W., Carlo D. J. and von Eschenhach A. C. (1987) Radioimmunological imaging of metastatic prostate cancer with In-111 labeled monoclonal antibody PAY-276. Urol. 137, 439-443.
3. Badalament R. A., Burgers J. K., Petty L. R., Mojzisik CM, Berens A, Marsh W, Hinkle G. H. and Martin E. W. Jr. (1993) Radioimmunoguided radical prostectomy and lymphadnectomy. Cancer 71, 2268-75.
4. 111In-DTPA-D-PHE]-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci. 49, 1593-1601.
5. 111In-DTPA-D-PHE]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor positive tumors: Synthesis, radiolabeling and in vitro validation. Life Sci. 49, 1583-1591.
6. Boring C. C., Squires T. C. and Tong T. (1992) Cancer Statistics. Ca: A Cancer Journal for Clinicians 42 (1), 19-38.
7. Breeman W. A. P., Hofland L. J., van der Pluijm M., von Koetsveld P. M., de Jong M., Setyono-Han B., Bakker W. H., Kwekkeboom D. J., Visser T. J. and Lamberts S. W.. (1994) A new radiolabeled Somatostatin analogue [In-111-DTPA-D-Phe1] RC-160: Preparation, biological activity, receptor scintigraphy in rats and comparison with [In-111-DTPA-D-Phe-1] Octreotide. Eur. J. Nucl. Med. 21, 328-335.
8. Brevini T. A., Bianchi R. and Motta M. (1995) Direct inhibitory effect of Somatostatin on the growth of the human prostatic cancer cell line LNCaP: Possible mechanism of action. J. Clin. Endocrinol. Met. 77, 626-31.
9. Bruns C., Weckbecker G., Raulf F., Kaupmann K., Schoeffer P., Hoyer D. and Lubbert H. (1996) Molecular pharmacology of somatostatin receptor subtypes. Ann. NY Acad. Sci. 733, 138-146.
10. Buscail L., Delesque N., Eseteve J. P., Saint-Laurent N., Prats H., Clerc P., Robberecht P., Bell G. I., Liebow C., Schally A. V., Vaysse N. and Susini C. (1994) Stimulation of tyrosine phosphse and inhibition of cell proliferation by somatostatin analogues: Mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc. Natl. Acad. Sci. 91, 2315-2319.
11. Buscail L., Esteve J. P., Saint-Laurent N., Bertrand V., Reisine T., O'Carroll A. M., Bell G. I., Schally A. V., Vaysse N. and Susini C. (1995). Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc Natl. Acad. Sci. 92, 1580-1584.
12. Haricak H., Dooms G. C., Jeffery R. B.. (1987) Prostatic carcinoma; Staging by clinical assessment, CT and MR imaging. Radiology 162, 331-336.
13. Hoosein N. M., Logothetis C. J., Chung L. W. K. (1993) Differential effects of peptide hormones Bombesin, vasoactive intestinal peptide and Somarostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. J Urol. 149, 1209-13.
14. Kavoussi L. R., Sosa E., Chandhoke P., Chodak G., Clayman R. V., Hadley H. R., Loughlin K. R., Ruckle H. C., Rukstalis D. and Schuessler W. (1993) Complications of laparoscopic pelvic lymph node dissection. J Urol. 149(2), 322-325.
15. Krenning E. P., Kwekkeboom D. J., Bakker W. H., Breeman W. A. Kooij P. P., Oei H. Y., van Hagen M., Postema P. T., de Jong M. and Reubi J. C. (1993) Somatostatin receptor scintigraphy with [In-111-DTPA-D-Phe] and [I-123-Tyr-3] octreotide; the Rotterdam experience with more than 1000 patients. Eur. J. Nucl. Med. 20, 716-731.
16. 111In-DTPA-Octreotide. Peptide Res. 9, 144-150.
17. Lamberts S. W., van der Lely A. J., Derherder W. W. and Hofland L. J. (1996) Octreotide. N. Engl. J. Med. 20 334, 246-254.
18. Manni A., Boucher A. E., Demers L. M., Harvey H. A., Lipton A., Simmonds M. A. and Bartholomew M. (1990) Somatostatin analogs in the treatment of breast and prostatic cancer. J Steriod. Biochem. Molec. Biol. 37, 1083-1087.
19. Milovanovic S. R., Radulovic S., Groot K. and Schally A. V. (1992) Inhibition growth of PC-82 human prostate cancer line xenografts in nude mice by Bombesin antagonist RC-3095 or combination of antagonist (D-Trp 6) luteinizing hormone-releasing hormone and Somatostatin analog RC-160. The Prostate 20, 269-280.
20. Neal C. E., Swenson L. C., Fanning J. and Texter J. (1993) Monoclonal antibodies in ovarian and prostate cancer. Semi. Nucl. Med. XXIII, 114-126.
21. Neal C. E., Mes L. C. (1994) Correlative imaging with monoclonal antibodies in colorectal, ovarian, and prostate cancer. Sem. Nucl. Med. 24(4), 272-285.
22. Perala M., Vihko P., Sodervall M., Heikkila J. and Vihko R. (1990) Biodistibution in normal mice of an In-111 labeled prostatic acid phosphatase specific antibody and its F(ab')2 fragments derivatized site specifically or via bicyclic DTPA anhydride. Eur. J. Nucl. Med. 16, 621-626.
23. Pinski J., Holmos G. and Schally A. V. (1993) Somatostatin analog RC-160 and Bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice. Cancer Lett. 71, 189-196.
24. Raynor K., Murphy W. A. and Coy D. H., et al. (1993) Cloned somatostatin receptors: Identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Mol. Pharmacol. 43, 838-844.
25. Raynor K., O'Carroll A. M. and Kong H., et al. (1993) Characterization of cloned somatostatin receptors SSTR4 and SSTR5. Mol. Pharmacol. 44, 385-392.
26. Rens-Domiano S., Law S. F., Yamada Y., et al. (1992) Pharmacological properties of two cloned somatostatin receptors. Mol. Pharmacol. 42, 28-34.
27. Reubi J. C., Laissue J., Waser B., Horisberger U. and Schaer J. C. (1994) Expressin of somatostatin receptors in normal, inflamed and neoplastic human gastrointestinal tissues. Ann. NY Acad. Sci. 733, 123-137.
28. Rifkin M. D., Zerhounin E. A. and Gastonia C. A. (1990) Comparison of MRI and ultrasonography in staging early prostate cancer. N. Engl. J. Med. 323, 621-626.
29. Schally A. V. (1988) Oncological applications of Somatostatin analogs. Cancer Res. 48, 6977-6985.
30. Studer M., and Kadeh T. A. (1986) One step synthesis of Mono-N-substituted Azamacrocycles with carboxylic group in the side chain and their complexes with Cu2+ and Ni2+. Helv. Chim. Acta 69, 2081-2086.
31. Texter J. H., Neal C. E. (1993) Current applications of immunoscintigraphy in prostate cancer. J Nucl. Med. 34, 549-553.
32. Thakur M. L. and DeFulvio J. (1991) Technetium-99m labeled monoclonal antibodies for immunoscintigraphy: Simplified preparation and evaluation. J. Immunol. Methods 137, 217-224.
33. 99mTc for imaging tumors: Preparation and preliminary evaluation. Int. J. Oncol. 9, 445-451.
34. Varnum J. M, Thakur M. L, Schally A. V., Jansen M. and Mayo K. H. (1994) Rhenium labeled Somatostatin analog RC-160 1H-NMR and computer modeling conformational analysis. J. Biol. Chem. 269, 12583-12588.
35. Yano T., Pinski J. and Szepeshazi K, Milovanovic S. R., Groot K., Schally A. V. (1990) Effect of microcapsules of LH-RH antagonist SB-75 and Somatostatin analog RC-160 on endocrine status and tumor growth in the Dunning R-3327H Rat Prostate Cancer Model. The Prostate 20, 297-310.
36. 188Re-RC-160: A directly labeled somatostatin analog. Int J Cancer 65(2), 214-220.